Literature DB >> 18629847

Biological and physical factors influencing the successful engraftment of a cultured human skin substitute.

N Parenteau1, M Sabolinski, S Prosky, C Nolte, M Oleson, K Kriwet, P Bilbo.   

Abstract

Skin tissue may be engineered in a variety of ways. Our cultured skin substitute (Graftskin, living skin equivalent or G-LSE), Apligraftrade mark, is an organotypic culture of skin, containing both a "dermis" and "epidermis." The epidermis is an important functional component of skin, responsible for biologic wound closure. The epidermis possesses a stratum corneum which develops with time in culture. The stratum corneum provides barrier function properties and gives the LSE improved strength and handling characteristics. Clinical experience indicated that the stratum corneum might play an important role in improving the clinical utility of the LSE. Handling and physical characteristics improved with time in culture. We examined the LSE at different stages of epidermal maturation for barrier function and ability to persist as a graft. LSE grafted onto athymic mice before significant development of barrier function did not withstand bandage removal at 7 days postgraft. LSE grafted after barrier function had been established in vitro were able to withstand bandage removal at day 7. Corneum lipid composition and structure are critical components for barrier function. Media modifications were used in an attempt to improve the fatty acid composition of the stratum corneum. The barrier developed more rapidly and was improved in a serum-free, lipid-supplemented condition. Lipid lamellar structure was improved with 10% of the stratum corneum exhibiting broad-narrow-broad lipid lamellar arrangements similar to human skin. Fatty acid metabolism was not appreciably altered. Barrier function in vitro was 4- to 10-fold more permeable than human skin. Epidermal differentiation does not compromise engraftment or the wound healing ability of the epidermis. The stratum corneum provides features beneficial for engraftment and clinical use. (c) 1996 John Wiley & Sons, Inc.

Entities:  

Year:  1996        PMID: 18629847     DOI: 10.1002/(SICI)1097-0290(19961005)52:1<3::AID-BIT1>3.0.CO;2-P

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  6 in total

1.  Vascularization of the dermal support enhances wound re-epithelialization by in situ delivery of epidermal keratinocytes.

Authors:  Liana M Lugo; Pedro Lei; Stelios T Andreadis
Journal:  Tissue Eng Part A       Date:  2010-12-18       Impact factor: 3.845

2.  Development of microfabricated dermal epidermal regenerative matrices to evaluate the role of cellular microenvironments on epidermal morphogenesis.

Authors:  Katie A Bush; George D Pins
Journal:  Tissue Eng Part A       Date:  2012-07-30       Impact factor: 3.845

3.  Evidence for keratinocyte stem cells in vitro: long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes.

Authors:  T M Kolodka; J A Garlick; L B Taichman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

4.  Designing tailored biomaterial surfaces to direct keratinocyte morphology, attachment, and differentiation.

Authors:  K A Bush; P F Driscoll; E R Soto; C R Lambert; W G McGimpsey; G D Pins
Journal:  J Biomed Mater Res A       Date:  2009-09-15       Impact factor: 4.396

5.  The importance of both fibroblasts and keratinocytes in a bilayered living cellular construct used in wound healing.

Authors:  Abigail M Wojtowicz; Steve Oliveira; Mark W Carlson; Agatha Zawadzka; Cecile F Rousseau; Dolores Baksh
Journal:  Wound Repair Regen       Date:  2014 Mar-Apr       Impact factor: 3.617

Review 6.  Tissue engineering of skin and regenerative medicine for wound care.

Authors:  Steven T Boyce; Andrea L Lalley
Journal:  Burns Trauma       Date:  2018-01-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.